======= A1CF =======
== Gene Information ==
* **Official Symbol**: A1CF
* **Official Name**: APOBEC1 complementation factor
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=29974|29974]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9NQ94|Q9NQ94]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=A1CF&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20A1CF|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/618199|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: Mammalian apolipoprotein B mRNA undergoes site-specific C to U deamination, which is mediated by a multi-component enzyme complex containing a minimal core composed of APOBEC-1 and a complementation factor encoded by this gene. The gene product has three non-identical RNA recognition motifs and belongs to the hnRNP R family of RNA-binding proteins. It has been proposed that this complementation factor functions as an RNA-binding subunit and docks APOBEC-1 to deaminate the upstream cytidine. Studies suggest that the protein may also be involved in other RNA editing or RNA processing events. Several transcript variants encoding a few different isoforms have been found for this gene. [provided by RefSeq, Nov 2010].
* **UniProt Summary**: N/A
|RRM 1|
|apolipoprotein B mRNA editing enzyme complex|
|mRNA localization resulting in posttranscriptional regulation of gene expression|
|intracellular mRNA localization|
|cytidine to uridine editing|
|base conversion or substitution editing|
|mRNA modification|
|single-stranded RNA binding|
|double-stranded RNA binding|
|mRNA binding|
|RNA modification|
|protein stabilization|
|RNA localization|
|regulation of protein stability|
|mRNA processing|
|posttranscriptional regulation of gene expression|
|mRNA metabolic process|
|RNA processing|
|endoplasmic reticulum|
|RNA binding|
|cellular macromolecule localization|
|RNA metabolic process|
|gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp458|Bisphenol S 100μM R08 exp458]]|-2.13|
|[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-1.95|
|[[:results:exp111|R-DABN 8μM R03 exp111]]|-1.85|
|[[:results:exp490|Hydroxychloroquine 30μM R08 exp490]]|-1.7|
|[[:results:exp249|Vinorelbine 0.001μM R05 exp249]]|1.74|
^Gene^Correlation^
|[[:human genes:h:hgc6.3|HGC6.3]]|0.4|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 6771
* **Expression level (log2 read counts)**: 1.03
{{:chemogenomics:nalm6 dist.png?nolink |}}